These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15531294)

  • 1. Visualization of naturally occurring Foxp3+ regulatory T cells in normal and tumor-bearing mice.
    Hontsu S; Yoneyama H; Ueha S; Terashima Y; Kitabatake M; Nakano A; Ito T; Kimura H; Matsushima K
    Int Immunopharmacol; 2004 Dec; 4(14):1785-93. PubMed ID: 15531294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling.
    Ordoñez-Rueda D; Lozano F; Sarukhan A; Raman C; Garcia-Zepeda EA; Soldevila G
    Eur J Immunol; 2009 Aug; 39(8):2233-47. PubMed ID: 19609976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Fontenot JD; Gavin MA; Rudensky AY
    Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
    Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
    Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
    Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
    Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
    Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
    Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice.
    Chiu BC; Stolberg VR; Zhang H; Chensue SW
    Mech Ageing Dev; 2007; 128(11-12):618-27. PubMed ID: 17961632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
    Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
    Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells.
    Pacholczyk R; Ignatowicz H; Kraj P; Ignatowicz L
    Immunity; 2006 Aug; 25(2):249-59. PubMed ID: 16879995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
    Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
    J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
    Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
    Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice.
    Polanczyk MJ; Hopke C; Huan J; Vandenbark AA; Offner H
    J Neuroimmunol; 2005 Dec; 170(1-2):85-92. PubMed ID: 16253347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
    Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
    Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.
    Mor A; Keren G; Kloog Y; George J
    Eur J Immunol; 2008 Jun; 38(6):1493-502. PubMed ID: 18461565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.
    Nishikawa H; Kato T; Tawara I; Saito K; Ikeda H; Kuribayashi K; Allen PM; Schreiber RD; Sakaguchi S; Old LJ; Shiku H
    J Exp Med; 2005 Mar; 201(5):681-6. PubMed ID: 15753203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.
    Morgan ME; van Bilsen JH; Bakker AM; Heemskerk B; Schilham MW; Hartgers FC; Elferink BG; van der Zanden L; de Vries RR; Huizinga TW; Ottenhoff TH; Toes RE
    Hum Immunol; 2005 Jan; 66(1):13-20. PubMed ID: 15620457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.